Headline:
The FDA’s harmful restrictions on two new COVID drugs
Publication Date:
Thursday, January 13, 2022
Primary Source:
Type:
op-ed
Format:
Newspaper (Print)
Nature of Mention:
authored
Scholar:
Research Area:
Attached Files:
Custom Description:
Jeffrey A. Singer and Josh Bloom authored an op-ed on the FDA's restrictions on the COVID-19 antiviral pills: "The FDA’s harmful restrictions on two new COVID drugs"